A role for tissue transglutaminase (TG2) and its substrate dual leucine zipper-bearing kinase (DLK), an upstream component of the c-Jun N-terminal kinase (JNK) signaling pathway, has been previously suggested in the apoptotic response induced by calphostin C. In the current study, we directly tested this hypothesis by examining via pharmacological and RNA-interference approaches whether inhibition of expression or activity of TG2, DLK and JNK in mouse NIH 3T3 fibroblasts and human MDA-MB-231 breast cancer epithelial cells affects calphostin C-induced apoptosis. Our experiments with the selective JNK inhibitor SP600125 reveal that calphostin C is capable of causing JNK activation and JNK-dependent apoptosis in both cell lines. Small interfering RNA-mediated depletion of TG2 alone strongly reduces calphostin C action on JNK activity and apoptosis. Consistent with an active role for DLK in this cascade of event, cells deficient in DLK demonstrate a substantial delay of JNK activation and poly-ADP-ribose polymerase (PARP) cleavage in response to calphostin C, whereas overexpression of a recombinant DLK resistant to silencing, but sensitive to TG2-mediated oligomerization, reverses this effect. Importantly, combined depletion of TG2 and DLK further alters calphostin C effects on JNK activity, Bax translocation, caspase-3 activation, PARP cleavage and cell viability, demonstrating an obligatory role for TG2 and DLK in calphostin C-induced apoptosis.
Calphostin C is a fungus-derived antibiotic that has been identified as a potent and selective inhibitor of protein kinase C. 1 A number of studies have demonstrated that calphostin C can induce apoptosis in different cellular backgrounds 2, 3 by mechanisms that are still largely unknown, but might include activation of caspase-3, 4 Bax translocation to the mitochondria 5 and inhibition of phospholipase D. 6 Because calphostin C has the ability to substantially increase intracellular Ca þ þ level, 3 it also rapidly and strongly switches on the crosslinking function of tissue transglutaminase (TG2) in various experimental systems. [7] [8] [9] TG2 is a multifunctional enzyme with a transamidating activity and has a role as a signal-transducing GTP-binding protein. 10, 11 As a member of the transglutaminase family, TG2 exhibits a Ca 2 þ -dependent covalent crosslinking activity that allows the formation of g-glutamyl-e-lysine isopeptide bonds within or between polypeptide chains and also allows the incorporation of polyamines into substrate proteins. Such transglutaminasemediated crosslinking of substrate proteins has been proposed to regulate important biological processes, such as apoptosis. [10] [11] [12] The role of TG2 in dying cells remains puzzling as it has been shown to promote or prevent apoptosis, depending on the cell context and the nature of the death stimulus. Recent studies from different laboratories have revealed that the positive or negative effects of TG2 on apoptosis are modulated by both its transamidating (e.g., protein crosslinking and polyamination) and non-transamidating (e.g., GTP binding/hydrolysis) functions. [13] [14] [15] Activation of the transamidating function of TG2 in cells undergoing spontaneous or stress-induced apoptosis has been found to cause the polymerization of specific cytosolic, cytoskeletal and nuclear substrate proteins, such as the retinoblastoma protein, 7 actin 16 and core histones, 17 which are thought to contribute in some way to the early and late stages of the apoptotic process.
We have reported previously that calphostin C-mediated death of cells such as NIH 3T3 fibroblasts and Neuro-2a neuroblastomas is associated with the rapid and dramatic downregulation of dual leucine zipper-bearing kinase (DLK), a mitogen-activated protein kinase kinase kinase (MAPKKK) of the stress-activated c-Jun N-terminal kinase (JNK) signaling pathway. 9 DLK downregulation in calphostin C-treated cells was found to be paralleled by the accumulation of high molecular weight DLK oligomers, the formation of which is almost completely antagonized by the transglutaminase inhibitor monodansylcadaverine. 9 Treatment with monodansylcadaverine prior to stimulation with calphostin C also blocked cleavage of the caspase substrate poly-ADP-ribose polymerase (PARP), suggesting that activation of TG2 is necessary to promote DLK oligomerization and to induce apoptosis. Interestingly, upon TG2-mediated oligomerization, ectopically expressed DLK was found to function as a constitutively active protein kinase, which in turn stimulates the JNK signaling pathway and sensitizes cells to calphostin C-induced apoptosis. Taken as a whole, these observations clearly argue for a role of DLK polymerization and subsequent JNK activation in the molecular mechanisms by which TG2 regulates calphostin C-induced apoptosis.
As a mean of exploring this notion further, we examined herein the contributory roles of endogenous TG2, DLK and JNK in calphostin C-induced apoptosis using pharmacological and RNA-interference approaches. Our results show that calphostin C causes apoptosis in mouse NIH 3T3 fibroblasts and human MDA-MB-231 breast cancer cells through activation of the JNK pathway. Knockdown of either TG2 or DLK significantly reduces calphostin C action on JNK activity and apoptosis, whereas combined depletion of both proteins attenuates this response even more. Furthermore, we show that TG2 knockdown blocks calphostin C-induced DLK oligomerization, confirming the crucial role played by TG2 in this response. Together, these data greatly extend our previous work done in cells with ectopic expression of TG2 and DLK 9 and demonstrate for the first time that endogenous TG2, DLK and JNK are part of a sequential signaling pathway that mediates the effects of calphostin C on apoptosis.
Results
Calphostin C-induced apoptosis in NIH 3T3 cells is mediated by the JNK signaling pathway. A role for JNK in cell-signaling events that are pro-apoptotic is well established. 18 In some cell types, such as in neurons, JNK has been recognized as an important regulator of cell death evoked by a variety of apoptotic stimuli, including excitotoxic stress, withdrawal of growth factors, DNA damage, oxidative stress and b-amyloid exposure. [19] [20] [21] [22] To investigate the relative contribution of JNK in calphostin C-induced apoptosis, we first examined by immunoblot analysis whether its phosphorylation on Thr-183 and Tyr-185, an indicator of activation, is induced in NIH 3T3 cells exposed to calphostin C for various times. In agreement with our previous findings, 8 a gradual and dramatic increase in JNK activity was detected as early as 45 min following treatment with 250 nM calphostin C (Figure 1a) , a dose known to decrease survival in several cell types. 23, 24 Concurrent immunoblotting of the lysates with an antibody insensitive to JNK phosphorylation state revealed that the total amount of JNK remained constant under these treatment conditions. Apoptosis was assessed in these cells by probing the lysates with antibodies against cleaved forms of caspase-3, one of the key effector molecules in apoptotic cell death, 25 and the caspase substrate PARP. 26 Results shown in Figure 1a indicate that calphostin C was able to stimulate the cleavage of caspase-3 as early as 75 min after initiation of the treatment whereas PARP cleavage occurred about 15 min earlier. To determine whether calphostin C-induced cleavage of caspase-3 and PARP was indeed attributable to JNK activation, we next performed immunoblotting experiments with NIH 3T3 cells pretreated with the JNK inhibitor SP600125 27 prior to calphostin C treatment. As shown in Figure 1a , SP600125 completely prevented the calphostin C-mediated accumulation of cleaved caspase-3 and PARP, thereby suggesting that JNK activation contributes to apoptosis in response to calphostin C.
As calphostin C-and JNK-mediated apoptosis was reported previously to be associated with the translocation of the proapoptotic protein Bax to mitochondria, 5,28 a process essential for cytochrome c release and induction of apoptosis, it was also of interest to determine whether calphostin C treatment induces the mitochondrial redistribution of Bax in NIH 3T3 cells and whether JNK activity is required for such an event.
To do so, NIH 3T3 cells were preincubated in the absence or in the presence of SP600125 for 60 min before being exposed to calphostin C and subjected to subcellular fractionation. As shown in Figure 1b , we found that treatment of NIH 3T3 cells with calphostin C for 60 or 120 min resulted in the gradual accumulation of Bax into mitochondria, an effect completely inhibited by SP600125. In contrast, the abundance of both the cytosolic marker a-tubulin and the mitochondrial marker citrate synthase in their respective cellular fraction was not altered by treatment with calphostin C. Our results also indicated that Bax mitochondrial translocation correlated with a decrease in cell viability as suggested by trypan blue exclusion assay, and that exposure of cells to SP600125 completely abolished the ability of calphostin C to induce cell death (Figure 1c) . Thus, these results are completely consistent with the idea that calphostin C promotes Bax translocation to mitochondria and death of NIH 3T3 cells through JNK activation.
Depletion of TG2 by shRNA antagonizes calphostin C-induced apoptosis. To investigate the role of TG2 in calphostin C-induced apoptosis, we first silenced the expression of endogenous TG2 by RNA interference in NIH 3T3 fibroblasts. Knockdown of TG2 was accomplished by infecting cells with a lentiviral vector carrying a short hairpin RNA (shRNA) that targets mouse and human TG2 mRNA (Sh-TG2). To exclude potential nonspecific effects, cells were also infected with an empty lentiviral vector or a lentiviral vector expressing a scrambled shRNA (Shscrambled). As depicted in Figure 2a , the Sh-TG2 construct abolished almost completely TG2 protein expression at 72 h after infection, whereas the empty or Sh-scrambled vector had no such effect. The intracellular level of actin was also unaffected by any of these constructs. Consistent with a reduction of TG2 expression, cells infected with Sh-TG2 showed significantly less basal transglutaminase activity than cells infected with the empty lentivirus ( Figure 2b ). The crosslinking activity remaining after TG2 knockdown was probably due to the presence, in these cells, of other transglutaminases, such as TG7, which are ubiquitously expressed 11 or, alternatively, due to the residual levels of TG2 protein.
With the Sh-TG2-infected cells in hand, we next examined the effects of TG2 depletion on calphostin C-induced DLK oligomerization, activation of JNK and PARP cleavage by western blotting with specific antibodies. When compared with cells infected with the empty or Sh-scrambled lentivirus, in which we detected downregulation of DLK as early as 30 min after exposure to calphostin C and the appearance of DLK oligomers 45 min later, TG2-depleted NIH 3T3 fibroblasts showed impaired DLK oligomerization in response to calphostin C treatment ( Figure 2c ). Furthermore, knockdown of TG2 substantially diminished calphostin C-stimulated phosphorylation of JNK and cleavage of PARP, thereby supporting the hypothesis that TG2 mediates induction of DLK oligomerization, JNK activation and cell death by calphostin C. In agreement with this, ectopic expression of His-tagged wildtype active rat DLK in TG2-depleted NIH 3T3 cells neither induced nor promoted JNK activation and PARP cleavage in response to calphostin C treatment ( Figure 2d ).
DLK knockdown prevents the induction of JNK phosphorylation and PARP cleavage by calphostin C. Since DLK is the only known protein kinase that serves as a substrate for TG2 in cells undergoing calphostin C-induced apoptosis, 11 we tested the hypothesis that its lowered DLK protein levels were less sensitive than cells infected with either the empty or the Sh-hDLK lentivirus to the effects of calphostin C on JNK activity (Figure 3b ). Indeed, calphostin C was able to stimulate the activation of JNK at 120 min in Sh-mDLK-infected cells compared to 45 min for the control cells. A similar delay in the response of Sh-mDLKinfected cells to calphostin C was observed when western blotting was carried out with the antibody raised against cleaved PARP (Figure 3b ). Therefore, these results suggest that DLK plays a major role in the cascade of events that links TG2 activation by calphostin C to stimulation of JNK activity and induction of cell death. To further confirm a role for DLK in calphostin C-induced apoptosis, we performed a 'rescue' experiment in Sh-mDLKinfected cells that had been transiently transfected with an expression vector encoding His-tagged wild-type rat DLK, a recombinant protein resistant to silencing by the Sh-mDLK lentiviral vector employed here but sensitive to TG2-mediated oligomerization. Twenty-four hours after transfection, cells were treated with calphostin C for various times, lysed and subjected to immunoblot analyses with antibodies against the His tag, phospho-JNK and cleaved PARP. As shown from our previous findings, depletion of DLK in Sh-mDLK-infected NIH 3T3 cells, which were transfected with an empty vector, resulted in activation of JNK and PARP cleavage at 90 or 120 min after exposure to calphostin C compared to 45 or 60 min for empty vector-infected cells (Figure 3c ). Importantly, reintroduction of an His-tagged wild-type rat DLK in these cells led to a small increase in the basal level of JNK activity and PARP cleavage, and this was further enhanced by calphostin C from 60 min onwards. Interestingly, despite its ability to oligomerize in response to calphostin C like the wild-type rat DLK (Figure 3c ), a catalytically inactive His-tagged rat DLK mutant failed to reverse the effects of DLK silencing on calphostin C-induced JNK activation and PARP cleavage. It thus appears that DLK, in its oligomerized and active form, acts as key regulator of the apoptotic response induced by calphostin C. (Figure 4b ). Consistent with these findings, shRNA knockdown of both TG2 and DLK completely abolished Bax translocation from cytosol to mitochondria in response to calphostin C (Figure 4c ) and prevented the loss of cell viability more efficiently than knockdown of TG2 or DLK alone (Figure 4d) . Together, these results show that TG2 and DLK are necessary for calphostin C action on JNK activity and cell death. Calphostin C-induced apoptosis of breast cancer cells is mediated by the TG2-DLK-JNK pathway. To further explore the biological relevance of the preceding results, we next investigated the contribution of TG2, DLK and JNK to calphostin C-induced apoptosis using as a model system the drug-resistant and metastatic human breast cancer cell line MDA-MB-231, which expresses high basal levels of TG2. 29 This issue was first addressed by examining in these cells whether calphostin C induces JNK activation and PARP cleavage, as it does in mouse NIH 3T3 fibroblasts, and whether pharmacological inhibition of JNK with SP600125 reverses its effects. Results shown in Figure 5a indicate that calphostin C was able to stimulate phosphorylation of JNK and PARP cleavage as early as 1 h after treatment of MDA-MB-231 cells. However, prior incubation with SP600125 substantially reduced calphostin C effects on JNK phosphorylation and PARP cleavage, indicating that JNK activation is sufficient to trigger the induction of apoptosis by this compound.
MDA-MB-231 cells infected with control lentivirus or lentivirus expressing shRNA against either TG2 (Sh-TG2) or human DLK (Sh-hDLK no. 2) were then used to examine how the absence of TG2, DLK or both proteins affects calphostin C-induced apoptosis. As shown in Figure 5b , the constructs efficiently and specifically knocked down expression of the endogenous TG2 and DLK in this model. Immunoblot analysis demonstrated that the knockdown of either TG2 or DLK strongly reduced calphostin C effects on JNK activity and PARP within the time period examined, although the combined depletion of these two enzymes further altered this response ( Figure 5c ). As expected from our studies in NIH 3T3 fibroblasts, the combined knockdown of TG2 and DLK in MDA-MB-231 cells also conferred better survival in response to calphostin C treatment than did depletion of TG2 or DLK alone (Figure 5d ). Taken together, these results indicate that calphostin C needs both TG2 and DLK to fully transduce its apoptotic signal in MDA-MB-231 cells.
Discussion
Calphostin C-mediated cell death has been previously reported to be associated with the TG2-dependent oligomerization and activation of DLK, an upstream component of the JNK signaling pathway. 9 In the present study, we used mouse NIH 3T3 fibroblasts and human MDA-MB-231 breast cancer epithelial cells as in vitro model systems to investigate the role of TG2, DLK and JNK in the mechanisms underlying cell death induced by calphostin C. Our data indicate that calphostin C exposure causes JNK activation, concomitantly with induction of apoptosis, as evidenced by Bax translocation to mitochondria, cleavage of caspase-3 and PARP as well as loss of cell viability. Interestingly, JNK seems to be indispensable for calphostin C action on apoptosis as inhibition of its activity by SP600125 markedly reduced this response. Thus, these results strongly suggest that JNK, in its active form, acts as an important mediator of calphostin C-induced apoptosis in NIH 3T3 fibroblasts and MDA-MB-231 epithelial cells. The notion that JNK might contribute to the pro-apoptotic properties of calphostin C is not completely unexpected because prior studies have demonstrated the existence of a tight connection between activation of this protein and apoptosis induction in cells exposed to a wide array of stresses, including UV irradiation, heat shock, proinflammatory cytokines and chemotherapeutic drugs. 18, 30 The involvement of JNK in apoptosis is also supported by the finding that primary fibroblasts prepared from JNK-deficient mouse embryos are resistant to cell death induced by UV irradiation. 31 Using an RNA-interference strategy, we found that the ability of calphostin C to induce JNK activation and apoptosis in NIH 3T3 fibroblasts and MDA-MB-231 cells was considerably reduced after TG2 depletion. This observation indicates that TG2 is a key component of the signaling pathway leading to JNK activation and induction of apoptotic cell death by calphostin C. Previous studies have established that TG2 modulates apoptosis in a stimulus-dependent manner. Data from Tucholski and Johnson 13 suggest that TG2 is proapoptotic when cells are exposed to stressors that increase its Ca 2 þ -dependent transamidating activity, but antiapoptotic under conditions in which its crosslinking activity remains latent. Several apoptotic stimuli, such as osmotic stress, 13 oxidative stress 32 and UV irradiation, 32 have been shown to activate the in situ crosslinking function of TG2, presumably due to an increase in intracellular concentrations of calcium. As calphostin C is another stressor able to activate the crosslinking function of TG2, 9 the mechanism of TG2-mediated activation of JNK and apoptosis is likely due to the polymerization of various protein substrates involved in the apoptotic process. Of all the TG2 substrates identified so far, 11 DLK is the only one with an established role in JNK activation, 33, 34 and its polymerization has been found to facilitate cell commitment to apoptosis in response to calphostin C. 9 This suggests that DLK might act as an effector of TG2 during calphostin C-induced apoptosis. Support for such a role for DLK is provided by our observations that (1) TG2 knockdown prevents the accumulation of DLK oligomers in response to calphostin C; (2) depletion of DLK markedly reduces calphostin C-induced JNK activation and PARP cleavage; and (3) reintroduction of wild-type rat DLK, but not kinase-defective DLK, in mouse-silenced NIH 3T3 cells restores calphostin C ability to stimulate JNK activity and PARP cleavage. Collectively, these results favor a model in which calphostin C induces apoptosis through a sequential pathway involving TG2, DLK, JNK and mitochondria ( Figure 6 ). Such a scenario is consistent with the previous observations that activation of TG2 by calphostin C leads to the oligomerization and stimulation of DLK, which, in turn, promotes the activation of JNK. 9 Further support for the idea that TG2 and DLK function in a linear pathway also derives from the present finding that combined knockdown of both proteins has additive effects in lowering JNK activation and cell death by calphostin C, compared to TG2 or DLK knockdown alone.
In conclusion, our current findings provide the first genetic evidence that TG2 and DLK play an essential role in the execution of calphostin C-induced apoptosis. Although the participation of other signaling pathways and kinases in this process cannot be excluded at present, our results also underscore the absolute requirement of JNK activity in regulation of TG2-mediated calphostin C-induced apoptosis. Understanding the mechanisms of apoptosis caused by TG2 has fundamental biological interest, because expression of TG2 and activation of its crosslinking function have been linked to both the development of neurodegenerative diseases [35] [36] [37] and the induction of death in drug-resistant cancer cells. 38, 39 Studies directed at identifying whether DLK forms homodimers and/or heterodimers with another cytosolic substrate in calphostin-treated cells should also provide valuable insights into the mechanisms by which DLK transduces an apoptotic signal. The rabbit polyclonal antiserum to DLK was described previously. 40 Rabbit polyclonal antibodies raised against cleaved caspase-3 and cleaved PARP were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). The rabbit polyclonal and the mouse monoclonal antibodies against g-actin and a-tubulin were obtained from Sigma-Aldrich Ltd. The rabbit polyclonal antibodies against Bax and TG2 as well as the mouse monoclonal antibodies against phospho-JNK and total JNK were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA.). Finally, the Cell culture. Mouse NIH 3T3 fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% (v/v) cosmic calf serum (CCS), 100 U/ml penicillin, 100 mg/ml streptomycin and 25 mg/ml amphotericin B. Human MDA-MB-231 breast cancer cells were maintained in DMEM supplemented with 10% (v/v) fetal bovine serum (CCS), 100 U/ml penicillin, 100 mg/ml streptomycin and 25 mg/ml amphotericin B. Both cell lines were maintained at 37 1C in a humidified atmosphere consisting of 5% CO 2 /95% air. Exposure to calphostin C (250 nM) was routinely carried out on late log (i.e. 90% confluent) cultures, in the continuous presence of fluorescent light. In some experiments (see Results), cells were preincubated with the JNK inhibitor SP600125 (20 mM) for 1 or 2 h before the addition of calphostin C. The final concentrations of diluent/vehicle (dimethylsulfoxide) never exceeded 0.1% (v/v).
Preparation of cell lysates and immunoblotting. Cells were lysed for 60 min at 4 1C in 15 mM Tris-HCl pH 7.4, 1% Triton X-100, 0.2% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 150 mM NaCl, 1 mM MgCl 2 , 1 mM EGTA, 10 mM b-mercaptoethanol, 0.2 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mg/ml leupeptin and 1 mg/ml aprotinin. Lysates were clarified by centrifugation (12 000 Â g for 10 min at 4 1C), and the concentration of total protein in the supernatant fraction was quantified by the modified Bradford protein assay (Bio-Rad Laboratories, Mississauga, Ontario, Canada). For immunoblotting, equal amounts of proteins were fractionated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride (PVDF) membranes (Roche Diagnostics, Laval, Québec, Canada) using a semidry transfer apparatus (Bio-Rad Laboratories). Membranes were blocked for 1 h at room temperature in 20 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween 20 containing 5% skim milk powder before overnight incubation with the primary antibody at 4 1C. Immunoreactive bands were detected by enhanced chemiluminescence using secondary HRP-conjugated antibodies (ECL Plus Western blotting kit; Amersham Pharmacia Biotech Inc.).
Mitochondria isolation. Mitochondria were isolated from parental NIH 3T3 and Sh-TG2 þ Sh-mDLK-infected NIH 3T3 cells incubated in the presence or absence of SP600125 and/or calphostin C using a mitochondria isolation kit from Pierce Biotechnology. The mitochondrial fractions were boiled in Laemli buffer, separated by SDS-PAGE and transferred to PVDF membranes for immunoblotting.
Cell viability assay. Control or infected NIH 3T3 and MDA-MB-231 cells incubated in the absence or presence of calphostin C (250 nM) were harvested with trypsin followed by staining with 0.4% trypan blue dye. The percentage of viable cells was determined using a hemocytometer. Cell viability (%) means the ratio of the number of trypan blue-impermeable cells to the total cell counts (trypan blueimpermeable cell number/total cell number). Lentivirus infection. Lentiviral stocks were prepared as previously reported using 293T cells as packaging cells (see http://www.tronolab.epfl. ch for details). Subconfluent NIH 3T3 and MDA-MB-231 cells were incubated with viral supernatants for 24 h, washed twice with phosphate-buffered saline (PBS) and incubated with normal medium for an additional 2 days. Then, the cells were treated with calphostin C for the indicated time points, harvested and processed for further analyses.
In situ TG2 activity assay. Empty vector-and Sh-TG2-infected NIH 3T3 cells were labeled for 2 h with 1 mM BAP. The cells were subsequently rinsed twice with PBS, harvested in lysis buffer (50 mM Tris-HCl pH 7.5, 0.3 M NaCl, 5 mM EGTA, 1 mM EDTA, 0.5% Triton X-100, 0.5% NP-40, 0.1 mM PMSF, 1 mg/ml leupeptin and 1 mg/ml aprotinin) and sonicated on ice. Protein concentration in the lysates were determined by a modified Bradford protein assay (Bio-Rad Laboratories). TG2 activity was quantified by measuring the transglutaminase-dependent incorporation of BAP into proteins by a microplate assay as described previously. 41 Plasmids and transfection. The full-length coding sequence of wild-type rat DLK, which shows one nucleotide mismatch with the mouse DLK shRNA described here, was inserted in frame with an His tag sequence in the pTriEx-4 expression vector (Novagen Inc., Madison, WI, USA). The expression vector for His-tagged catalytically inactive rat DLK was produced by replacing the invariant lysine at position 185 within kinase subdomain II with arginine using the Stratagene QuickChange site-directed mutagenesis kit (La Jolla, CA, USA). For the 'rescue' experiment, NIH 3T3 cells were infected with an empty lentiviral vector or a lentiviral Figure 6 Proposed model for the regulation of calphostin C-induced apoptosis by TG2, DLK and JNK. In NIH 3T3 and MDA-MB-231 cells, calphostin C activates the crosslinking function of TG2 as a result of its ability to induce calcium mobilization. Once activated, TG2 catalyzes the formation of DLK oligomers capable of causing sustained activation of JNK, which in turn promotes Bax translocation to mitochondria and the subsequent caspase-dependent apoptosis. It is worth noting that the possibility that calphostin C triggers a TG2-independent pathway to induce cell death beyond the time period examined cannot be ruled out completely vector expressing mouse DLK shRNA and transfected, 48 h later, with the different expression vectors mentioned above using PolyFect transfection reagent (Qiagen, Valencia, CA, USA). Twenty-four hours after transfection, cells were treated with calphostin C (250 nM) for the indicated time points, harvested and processed for further analyses.
